Clinical Trials List
2023-12-01 - 2027-03-01
Phase I/II
Recruiting5
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- Ya-Ting Hsu Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- Sin-Syue Li Division of Hematology & Oncology
- 楊媛甯
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHENG-HSIEN LIN Division of Hematology & Oncology
- PO-HSIEN LI Division of Hematology & Oncology
- PO-WEI LIAO
- Tsung -Chih Chen Division of Hematology & Oncology
- 鄧齡喬 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李思慧
- SHIANN-TANG JOU
- Tai-Chung Huang Division of General Internal Medicine
- Chieh-Lung Cheng Division of General Internal Medicine
- 田豐銘
- Wen-Chien Chou
- Chien-Chin Lin Division of Others -
- - - Division of Hematology & Oncology
- YUNG-LI YANG Division of Others -
- Shang-Ju Wu
- HSIN-AN HOU Division of General Internal Medicine
- 張修豪 Division of Pediatrics
- CHENG-HONG TSAI Division of General Internal Medicine
- 杜佳叡
- 林明恩 Division of General Internal Medicine
- YAO CHI-YUAN Division of Others -
- Huai-Hsuan Huang Division of General Internal Medicine
- MENG-YAO LU Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tang-Her Jaing
- 張從彥
- 詹筑伊
- 王奕倫 Division of Pediatrics
- 莊覲瑄 Division of Hematology & Oncology
- HSUAN JEN SHIH
- Shih-Hsiang Chen
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
251 participants
